HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hathcock, J. N Articles by Heaney, R. Search for Related Content PubMed PubMed Citation Articles by Hathcock, J. N Articles by Heaney, R. Agricola Articles by Hathcock, J. N Articles by Heaney, R.

Risk assessment for vitamin D^1,2

¹ From the Council for Responsible Nutrition, Washington, DC (JNH and AS); Mount Sinai Hospital, Toronto, Canada (RV); and Creighton University, Omaha, Nebraska (RH)

The objective of this review was to apply the risk assessment methodology used by the Food and Nutrition Board (FNB) to derive a revised safe Tolerable Upper Intake Level (UL) for vitamin D. New data continue to emerge regarding the health benefits of vitamin D beyond its role in bone. The intakes associated with those benefits suggest a need for levels of supplementation, food fortification, or both that are higher than current levels. A prevailing concern exists, however, regarding the potential for toxicity related to excessive vitamin D intakes. The UL established by the FNB for vitamin D (50 µg, or 2000 IU) is not based on current evidence and is viewed by many as being too restrictive, thus curtailing research, commercial development, and optimization of nutritional policy. Human clinical trial data published subsequent to the establishment of the FNB vitamin D UL published in 1997 support a significantly higher UL. We present a risk assessment based on relevant, well-designed human clinical trials of vitamin D. Collectively, the absence of toxicity in trials conducted in healthy adults that used vitamin D dose 250 µg/d (10 000 IU vitamin D₃) supports the confident selection of this value as the UL.

Key Words: Vitamin D • risk assessment • Tolerable Upper Intake Level • UL

This article has been cited by other articles:

				L. Rejnmark, P. Vestergaard, L. Heickendorff, and L. Mosekilde Plasma 1,25(OH)2D levels decrease in postmenopausal women with hypovitaminosis D. Eur. J. Endocrinol., April 1, 2008; 158(4): 571 - 576. [Abstract] [Full Text] [PDF]

				J.E. Chavarro, J.W. Rich-Edwards, B. Rosner, and W.C. Willett Reply: Calcium homeostasis and anovulatory infertility Hum. Reprod., December 1, 2007; 22(12): 3265 - 3265. [Full Text] [PDF]

				M. J. Rowling, C. Gliniak, J. Welsh, and J. C. Fleet High Dietary Vitamin D Prevents Hypocalcemia and Osteomalacia in CYP27B1 Knockout Mice J. Nutr., December 1, 2007; 137(12): 2608 - 2615. [Abstract] [Full Text] [PDF]

				R. P Heaney and J. M Lappe Reply to MM Sood and AR Sood Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1549 - 1550. [Full Text] [PDF]

				E. Giovannucci Can Vitamin D Reduce Total Mortality? Arch Intern Med, September 10, 2007; 167(16): 1709 - 1710. [Full Text] [PDF]

				S. M Kimball, M. R Ursell, P. O'Connor, and R. Vieth Safety of vitamin D3 in adults with multiple sclerosis Am. J. Clinical Nutrition, September 1, 2007; 86(3): 645 - 651. [Abstract] [Full Text] [PDF]

				R. Vieth, H. Bischoff-Ferrari, B. J Boucher, B. Dawson-Hughes, C. F Garland, R. P Heaney, M. F Holick, B. W Hollis, C. Lamberg-Allardt, J. J McGrath, et al. The urgent need to recommend an intake of vitamin D that is effective Am. J. Clinical Nutrition, March 1, 2007; 85(3): 649 - 650. [Full Text] [PDF]